{"id":"NCT00233402","sponsor":"Photocure","briefTitle":"Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy","officialTitle":"A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2008-07","completion":"2008-08","firstPosted":"2005-10-05","resultsPosted":"2013-10-11","lastUpdate":"2013-10-11"},"enrollment":789,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":null},"conditions":["Bladder Cancer"],"interventions":[{"type":"DRUG","name":"Hexvix","otherNames":[]},{"type":"PROCEDURE","name":"Standard white light cystoscopy","otherNames":[]}],"arms":[{"label":"Standard White Light Cystoscopy","type":"ACTIVE_COMPARATOR"},{"label":"Standard White Light and Hexvix Fluorescence Cystoscopy","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to document the additional detection of papillary bladder cancer and the reduced early recurrence due to the improved detection and resection of these tumors after Hexvix cystoscopy compared to standard cystoscopy in patients with papillary bladder cancer.","primaryOutcome":{"measure":"Proportion of Patients With >= 1 Ta or T1 Tumor Detected With Blue Light and Not White Light","timeFrame":"Day 0","effectByArm":[{"arm":"Hexvix Group","deltaMin":16.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":25,"countries":["United States","Austria","Canada","Germany","Netherlands"]},"refs":{"pmids":["20850152"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":381},"commonTop":["Hematuria","Dysuria","Urinary tract infection","Procedural pain","Bladder spasm"]}}